Sulfones

Pharmacological classification and mechanism of action

The sulfone group represents an important class of antibacterial chemotherapeutic agents. According to the pharmacological classification, the main representative of this group—dapsone—belongs to the broad class of sulfonamides. This classification is not accidental, as these drugs share an absolutely identical mechanism of antimicrobial action at the cellular level.

The key target for sulfones in the bacterial cell is a specific enzyme—dihydropteroate synthase. Drugs of this group directly inhibit this enzyme. By blocking dihydropteroate synthase, sulfones interfere with critical metabolic cascades of the microorganism, ultimately leading to the cessation of its growth and reproduction.

Main representatives and spectrum of clinical application

In clinical pharmacology, several key drugs are distinguished within the sulfone group. The basic and most significant medication, the reference standard of the group, is dapsone. In addition to it, clinicians have its structural and functional analogues—solasulfone and diucifon.

All listed drugs (dapsone, solasulfone, and diucifon) share similar pharmacological properties. They are united by high specific activity against Mycobacterium leprae. Therefore, the primary and historically most important indication for the entire sulfone group is the comprehensive therapy of leprosy.

However, the spectrum of activity of dapsone is not limited to mycobacteria alone. This drug has another critically important indication: it is effectively used to treat severe specific respiratory tract infections, namely—pneumonia caused by Pneumocystis carinii (pneumocystis pneumonia).

Rational combination therapy

In modern medical practice, sulfones, particularly dapsone, are rarely used as isolated monotherapy. To achieve maximum clinical results, a strategy of combined drug administration is used.

Most often, dapsone is used in strict combination with such drugs as trimethoprim or pyrimethamine. The main pharmacological goal of creating such combinations is to achieve a pronounced synergistic effect. Synergism implies that the combined action of two drugs significantly exceeds the simple sum of their isolated effects, ensuring a more potent and reliable suppression of pathogenic microorganisms.

Specific toxicity and genetic risk factors

Despite high clinical efficacy, sulfone therapy is associated with the risk of serious adverse reactions. The most specific and dangerous manifestation of dapsone toxicity is methemoglobinemia—a condition in which the oxygen-transport function of the blood is impaired. According to statistical data, this complication develops in approximately 5% of patients receiving therapy.

The pathogenesis of methemoglobinemia has a clear biochemical rationale and directly depends on the patient's genetic status. Chemically, dapsone belongs to the group of oxidizing agents. In a healthy body, erythrocytes are reliably protected from the damaging action of oxidants due to the function of a special enzyme—glucose-6-phosphate dehydrogenase (G6PD). This enzyme is critically essential for detoxification processes within red blood cells.

However, in clinical practice, patients with congenital G6PD deficiency in erythrocytes are frequently encountered. In such individuals, the natural antioxidant defense system functions improperly. As a result, dapsone intake induces massive oxidative stress in their erythrocytes, which naturally and rapidly leads to the development of methemoglobinemia.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• The mechanism of dihydropteroate synthase inhibition by sulfonamides and sulfones.
• Characteristics of the Pneumocystis carinii pathogen and the pathogenesis of pneumocystis pneumonia.
• Pharmacodynamics of synergism when combining dapsone with trimethoprim or pyrimethamine.
• The biochemical role of glucose-6-phosphate dehydrogenase (G6PD) in protecting erythrocytes from oxidants.
• Pathogenesis of drug-induced methemoglobinemia.

Other topics in the section "Antibacterial Chemotherapeutic Agents"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.